Workflow
Bank supervision
icon
Search documents
Federal Reserve releases new guidance for bank oversight in move praised by industry
Yahoo Finance· 2025-11-18 23:36
Core Viewpoint - The Federal Reserve has introduced new guidelines aimed at enhancing the supervision of the financial system, focusing on material financial risks rather than procedural compliance, which has garnered both praise and criticism from various stakeholders [1][2][4]. Regulatory Changes - The new principles emphasize that bank examiners should concentrate on material financial risks and avoid excessive focus on processes and documentation [2]. - Under the new rules, banks will be tested primarily for material risks to their businesses or balance sheets, such as bad loans or unsound business practices [5]. - Banks will also have the ability to self-certify on certain risk and supervision issues, a change that has been a priority for the banking industry since the Trump administration [5]. Industry Reactions - Industry trade groups have praised the new guidelines, indicating that prioritizing material financial risks will enhance the resilience of banks [6]. - Conversely, former Fed governor Michael Barr criticized the changes, warning that they may weaken supervision and make it more difficult for examiners to act against excessive risk buildup [4].
Financial Markets Buzz: Barr’s Supervision Warning, Pfizer’s Debt Move, Motorola’s Dividend Hike, and Paramount Skydance’s WBD Deal Denial
Stock Market News· 2025-11-18 19:08
Group 1: Banking Supervision - Federal Reserve Governor Michael S. Barr emphasized the need for strong banking supervision to ensure a healthy banking system, warning against pressures to weaken oversight which could pose dangers to the public [2][3][8] - Barr criticized plans to reduce staffing in the Fed's Supervision and Regulation division by 30% by the end of 2026, arguing that such cuts would hinder the ability to manage risks effectively [3][8] Group 2: Pfizer's Debt Offering and Acquisition - Pfizer launched a $6 billion debt offering structured in seven parts to finance its acquisition of Metsera, an obesity drug developer [4][8] - The acquisition is competitive, with Pfizer initially agreeing to a $4.9 billion purchase, but facing a higher bid from Novo Nordisk at $10 billion, leading Pfizer to file lawsuits against Novo Nordisk's bid [5][8] Group 3: Motorola Solutions Dividend Increase - Motorola Solutions announced an 11% increase in its quarterly dividend, raising it to $1.21 per share from $1.09, reflecting strong financial health and commitment to shareholder value [6][8] Group 4: Paramount Skydance and Warner Bros. Discovery - Paramount Skydance denied a report regarding a potential deal with Warner Bros. Discovery, stating the information was inaccurate and emphasizing the confidentiality of ongoing discussions [7][9] - Speculation continues around Paramount Skydance's interest in Warner Bros. Discovery, with previous bids deemed too low by Warner Bros. Discovery's board [9]